Azetidine and pyrrolidine PARP1 inhibitors and uses thereof

MYPI2025006356A0Undetermined Publication Date: 2023-04-01XINTHERA INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025006356
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2022-08-31
Filing Date
2022-09-30
Publication Date
2023-04-01
Patent Text Reader

Abstract

Described herein are azetidine and pyrrolidine PARP1 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of cancer.
Need to check novelty before this filing date? Find Prior Art